OBJECTIVE: Stiffness is a well-recognized symptom of rheumatoid arthritis (RA). It is frequently queried during clinic visits as an indicator of disease activity and was included in the 1961 and 1987 RA classification criteria. Little is known about how people with RA experience stiffness and its impact on their lives. METHODS: We conducted 4 focus groups including 20 people with RA (4-6 participants per group) from 1 academic clinical practice and 1 private practice to generate accounts of stiffness experiences. Qualitative inductive thematic data analysis was conducted. RESULTS: Five overarching themes were identified: relationship of stiffness with other symptoms, exacerbating or alleviating factors and self-management, stiffness timing and location, individual meanings of stiffness experiences, and impact of stiffness on daily life. CONCLUSION: Focus group discussions revealed individual stiffness experiences as diverse and complex. Several stiffness features were endorsed by a majority of participants, but few, if any, were universally experienced; thus, the significance of stiffness as an expression of the disease varied widely. Discussions yielded descriptions of how individual limits imposed by RA in general and stiffness in particular may change over time and were intertwined with adaptations to preserve participation in valued life activities. These results concerning the diversity of the stiffness experience, consequential adaptations, and its impact suggest that a more individualized approach to stiffness measurement may be needed to improve stiffness assessments.
OBJECTIVE: Stiffness is a well-recognized symptom of rheumatoid arthritis (RA). It is frequently queried during clinic visits as an indicator of disease activity and was included in the 1961 and 1987 RA classification criteria. Little is known about how people with RA experience stiffness and its impact on their lives. METHODS: We conducted 4 focus groups including 20 people with RA (4-6 participants per group) from 1 academic clinical practice and 1 private practice to generate accounts of stiffness experiences. Qualitative inductive thematic data analysis was conducted. RESULTS: Five overarching themes were identified: relationship of stiffness with other symptoms, exacerbating or alleviating factors and self-management, stiffness timing and location, individual meanings of stiffness experiences, and impact of stiffness on daily life. CONCLUSION: Focus group discussions revealed individual stiffness experiences as diverse and complex. Several stiffness features were endorsed by a majority of participants, but few, if any, were universally experienced; thus, the significance of stiffness as an expression of the disease varied widely. Discussions yielded descriptions of how individual limits imposed by RA in general and stiffness in particular may change over time and were intertwined with adaptations to preserve participation in valued life activities. These results concerning the diversity of the stiffness experience, consequential adaptations, and its impact suggest that a more individualized approach to stiffness measurement may be needed to improve stiffness assessments.
Authors: Ruben Tavares; George A Wells; Vivian P Bykerk; Francis Guillemin; Peter Tugwell; Mary J Bell Journal: J Rheumatol Date: 2013-02-01 Impact factor: 4.666
Authors: Nasim A Khan; Horace J Spencer; Esam Abda; Amita Aggarwal; Rieke Alten; Codrina Ancuta; Daina Andersone; Martin Bergman; Jurgen Craig-Muller; Jacqueline Detert; Lia Georgescu; Laure Gossec; Hisham Hamoud; Johannes W G Jacobs; Ieda Maria Magalhaes Laurindo; Maria Majdan; Antonio Naranjo; Sapan Pandya; Christof Pohl; Georg Schett; Zahraa I Selim; Sergio Toloza; Hisahi Yamanaka; Tuulikki Sokka Journal: Arthritis Care Res (Hoboken) Date: 2012-02 Impact factor: 4.794
Authors: Maarten Boers; John R Kirwan; George Wells; Dorcas Beaton; Laure Gossec; Maria-Antonietta d'Agostino; Philip G Conaghan; Clifton O Bingham; Peter Brooks; Robert Landewé; Lyn March; Lee S Simon; Jasvinder A Singh; Vibeke Strand; Peter Tugwell Journal: J Clin Epidemiol Date: 2014-02-28 Impact factor: 6.437
Authors: Frank Buttgereit; Daksha Mehta; John Kirwan; Jacek Szechinski; Maarten Boers; Rieke E Alten; Jerzy Supronik; Istvan Szombati; Ulrike Romer; Stephan Witte; Kenneth G Saag Journal: Ann Rheum Dis Date: 2012-05-05 Impact factor: 19.103
Authors: Dana E Orange; Nathalie E Blachere; Edward F DiCarlo; Serene Mirza; Tania Pannellini; Caroline S Jiang; Mayu O Frank; Salina Parveen; Mark P Figgie; Ellen M Gravallese; Vivian P Bykerk; Ana-Maria Orbai; Sarah L Mackie; Susan M Goodman Journal: Arthritis Rheumatol Date: 2020-02-12 Impact factor: 10.995
Authors: Jessica A B van Nies; Celina Alves; Audrey L S Radix-Bloemen; Cécile Gaujoux-Viala; Tom W J Huizinga; Johanna M W Hazes; Elisabeth Brouwer; Bruno Fautrel; Annette H M van der Helm-van Mil Journal: Arthritis Res Ther Date: 2015-04-23 Impact factor: 5.156
Authors: Susan J Bartlett; Vivian P Bykerk; Roxanne Cooksey; Ernest H Choy; Rieke Alten; Robin Christensen; Daniel E Furst; Francis Guillemin; Serena Halls; Sarah Hewlett; Amye L Leong; Anne Lyddiatt; Lyn March; Pamela Montie; Ana Maria Orbai; Christoph Pohl; Marieke Scholte Voshaar; Thasia G Woodworth; Clifton O Bingham Journal: J Rheumatol Date: 2015-02-15 Impact factor: 4.666
Authors: Alison Keogh; Niladri Sett; Seamas Donnelly; Ronan Mullan; Diana Gheta; Martina Maher-Donnelly; Vittorio Illiano; Francesc Calvo; Jonas F Dorn; Brian Mac Namee; Brian Caulfield Journal: Digit Biomark Date: 2020-09-23